V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010397 | 310003985 | 1.78 | null | Curative (C) | null | 2015-10-25 | IVE | N | N | 310010311 | IVE |
| 310010398 | 310003990 | 1.59 | 66.2 | Palliative (P) | 2013-12-08 | 2013-12-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | 310010525 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010399 | 310003995 | 1.19 | 72.5 | Disease modification (D) | 2016-11-30 | 2016-11-30 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | Y | N | 310010632 | NOT MATCHED |
| 310010401 | 310003999 | 0 | 90.7 | Disease modification (D) | 2018-07-21 | 2018-07-25 | Brentuximab Vedotin | N | N | 310010664 | BRENTUXIMAB |
| 310010404 | 310007658 | 1.67 | null | Palliative (P) | 2015-08-25 | 2015-08-26 | CISPLATIN + GEMCITABINE | N | null | 310011027 | CISPLATIN + GEMCITABINE |
| 310010405 | 310004015 | 1.18 | 25.2 | Palliative (P) | 2015-04-15 | 2015-11-05 | Interferon alfa + Zidovudine | N | N | 310011044 | NOT MATCHED |
| 310010406 | 310004020 | null | 82 | Palliative (P) | 2014-07-15 | 2014-08-31 | CISPLATIN + GEMCITABINE | N | null | 310011181 | CISPLATIN + GEMCITABINE |
| 310010407 | 310004024 | 1.47 | 55 | Palliative (P) | 2019-09-06 | 2019-09-14 | Carboplatin + Liposomal Doxorubicin | N | N | 310011273 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010408 | 310004029 | 1.68 | 53.6 | Curative (C) | 2015-03-25 | 2015-04-03 | Brentuximab Vedotin | 02 | N | 310011381 | BRENTUXIMAB |
| 310010409 | 310004030 | 1.5 | 60.1 | Curative (C) | 2017-08-28 | 2018-02-01 | GEMCITABINE | N | N | 310011561 | GEMCITABINE |
| 310010410 | 310004034 | 1.58 | 58.2 | Palliative (P) | 2018-07-02 | 2018-07-05 | Carboplatin + Liposomal Doxorubicin | N | N | 310011581 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010411 | 310010616 | 0 | null | Curative (C) | 2017-05-18 | 2017-05-19 | NB HRNBL-1 TVD | N | N | 310011701 | NOT MATCHED |
| 310010412 | 310004037 | 1.62 | 53.2 | Palliative (P) | null | 2017-06-08 | PEMBROLIZUMAB | 02 | N | 310011707 | PEMBROLIZUMAB |
| 310010413 | 310007670 | 1.7 | 78.3 | Palliative (P) | 2015-06-16 | 2015-06-19 | BEAM | 2 | N | 310012033 | BEAM |
| 310010414 | 310004043 | 1.55 | 63 | Palliative (P) | 2019-01-17 | 2019-02-15 | null | N | N | 310012063 | NOT MATCHED |
| 310010415 | 310004049 | 1.62 | 67.3 | Adjuvant (A) | null | 2016-01-13 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 310012172 | CISPLATIN + GEMCITABINE |
| 310010416 | 310004056 | 1.69 | 88.6 | Palliative (P) | 2016-11-24 | 2017-01-17 | GEM-P | N | N | 310012277 | GEMCITABINE + PACLITAXEL |
| 310010417 | 310004057 | null | 63 | Disease modification (D) | null | 2015-12-11 | IVE | 02 | N | 310012313 | IVE |
| 310010418 | 310004063 | 1.75 | 72.4 | Palliative (P) | 2016-08-03 | 2018-01-24 | GEM-P | N | N | 310012562 | GEMCITABINE + PACLITAXEL |
| 310010419 | 310004069 | 0 | 71.4 | Curative (C) | 2018-07-18 | 2018-07-18 | CISPLATIN + GEMCITABINE | 02 | N | 310012758 | CISPLATIN + GEMCITABINE |
| 310010420 | 310004070 | 1.53 | 91.7 | Palliative (P) | 2019-04-25 | 2019-04-25 | Carboplatin + Liposomal Doxorubicin | N | N | 310012763 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010421 | 310004075 | 1.57 | 54.3 | Palliative (P) | 2018-11-03 | 2018-11-03 | PEMBROLIZUMAB | N | N | 310012944 | PEMBROLIZUMAB |
| 310010422 | 310004082 | 1.63 | 117.3 | Palliative (P) | 2019-02-15 | 2019-03-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310013044 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010423 | 310007691 | 1.78 | 62 | Curative (C) | null | 2017-04-29 | LEAM | null | null | 310013083 | LEAM |
| 310010424 | 310007694 | 1.63 | 94 | Palliative (P) | 2016-04-26 | 2016-06-15 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310013153 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010425 | 310004095 | null | 82 | Palliative (P) | 2013-11-29 | 2016-05-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310013191 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010426 | 310004100 | 1.86 | null | Palliative (P) | 2015-10-20 | 2015-11-05 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310013495 | CISPLATIN + GEMCITABINE |
| 310010427 | 310010625 | 1.82 | 80.8 | Palliative (P) | 2019-01-10 | 2019-02-03 | Carboplatin + Liposomal Doxorubicin | N | Y | 310013542 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010428 | 310007704 | 1.64 | 82.9 | Palliative (P) | 2018-01-21 | 2018-01-25 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310013899 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010429 | 310004109 | 1.74 | 63.2 | Curative (C) | 2016-10-24 | 2016-10-24 | CISPLATIN + GEMCITABINE | N | N | 310013974 | CISPLATIN + GEMCITABINE |
| 310010430 | 310004115 | 1.58 | 60 | Palliative (P) | 2015-07-08 | 2015-07-10 | BEAM | 02 | N | 310014178 | BEAM |
| 310010431 | 310007711 | 1.54 | 78.5 | Palliative (P) | 2019-06-08 | 2019-06-08 | Carboplatin + Liposomal Doxorubicin | N | N | 310014179 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010432 | 310004131 | 1.78 | 99.6 | Palliative (P) | 2016-08-29 | 2016-08-31 | GEM-P | 02 | N | 310014287 | GEMCITABINE + PACLITAXEL |
| 310010433 | 310004135 | null | 60.4 | Palliative (P) | 2017-01-29 | 2017-01-30 | PEMBROLIZUMAB | 2 | N | 310014361 | PEMBROLIZUMAB |
| 310010434 | 310004138 | 1.71 | 74.9 | null | null | 2014-11-26 | PEMBROLIZUMAB | N | N | 310014426 | PEMBROLIZUMAB |
| 310010435 | 310004146 | 1.68 | 91.3 | Palliative (P) | 2017-05-29 | 2017-06-14 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310014478 | CISPLATIN + GEMCITABINE |
| 310010436 | 310004148 | 1.61 | 52.9 | Curative (C) | 2015-11-26 | 2015-12-09 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310014483 | CISPLATIN + GEMCITABINE |
| 310010437 | 310004160 | 1.59 | 74 | Palliative (P) | 2018-05-02 | 2018-05-05 | LEAM | N | N | 310014597 | LEAM |
| 310010439 | 310009623 | 1.64 | 70 | Palliative (P) | 2014-12-15 | 2014-12-20 | Gemcitabine weekly | N | N | 310014692 | GEMCITABINE |
| 310010440 | 310009623 | 1.69 | 90.2 | Curative (C) | 2016-04-09 | 2016-05-01 | IVE | N | N | 310014692 | IVE |
| 310010441 | 310004170 | 1.63 | 49.6 | Palliative (P) | 2017-01-23 | 2017-01-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310014746 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010442 | 310004171 | 1.73 | 89.6 | null | 2014-05-17 | 2014-05-18 | IVE | 02 | null | 310014773 | IVE |
| 310010444 | 310004177 | 1.55 | 95.6 | Palliative (P) | 2018-03-09 | 2018-03-16 | Carboplatin + Liposomal Doxorubicin | 2 | null | 310014855 | CARBOPLATIN + LIPOSOMAL DOX |
| 310010445 | 310004181 | 1.65 | null | Curative (C) | 2016-03-09 | 2016-03-31 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310014873 | CISPLATIN + GEMCITABINE |
| 310010446 | 310004186 | 1.88 | 77 | Palliative (P) | null | 2017-07-11 | PEMBROLIZUMAB | N | N | 310014958 | PEMBROLIZUMAB |
| 310010447 | 310004190 | 1.96 | 89.6 | Disease modification (D) | 2017-05-13 | 2017-05-16 | GEM-P | 2 | N | 310014972 | GEMCITABINE + PACLITAXEL |
| 310010448 | 310007747 | 1.81 | 50.5 | Palliative (P) | 2017-01-28 | 2017-01-28 | CISPLATIN + GEMCITABINE | N | N | 310014991 | CISPLATIN + GEMCITABINE |
| 310010449 | 310004201 | 1.5 | 59.2 | Palliative (P) | 2016-05-02 | 2016-05-06 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310015002 | GEMCITABINE |
| 310010450 | 310004204 | null | 95 | Not known (9) | 2013-03-25 | 2013-04-06 | PEMBROLIZUMAB | 02 | N | 310015039 | PEMBROLIZUMAB |
| 310010451 | 310004210 | 1.69 | 61.6 | Curative (C) | 2013-12-08 | 2014-08-27 | LEAM | N | N | 310015060 | LEAM |